Letter

ASCOT: a tale of two treatment regimens

BMJ 2005; 331 doi: 10.1136/bmj.331.7523.1022 (Published 27 October 2005)
Cite this as: BMJ 2005;331:1022.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Don't lose your head over ASCOT

  1. David G Phizackerley, prescribing team manager (david.phizackerley@wsx-pct.nhs.uk)
  1. Western Sussex Primary Care Trust, Chichester PO19 6FX

    EDITOR—McDougall et al reviewed the evidence from ASCOT (the Anglo Scandinavian cardiac outcomes trial).1 For patients with hypertension and for the clinicians helping to manage their blood pressure this must be the best of times and the worst of times. The best of times—currently we have a wealth of clinical trials on the management of blood pressure, giving us a mass of data, statistics and information to absorb. The worst of times—whenever a new trial is published, the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular